Clinical scale cultivation of MSCs

The demand for xeno-free and GMP-compliant production of clinical-scale mesenchymal stem cells (MSCs) as well as standardized quality control measures for cellular products is rising.

Kathrin Godthardt, Senior Scientist, R&D Department, Miltenyi Biotec, shows xeno-free MSC expansion solutions and workflows for qualifying the quality and phenotype of culture expanded MSCs. Furthermore, the CliniMACS Prodigy will be introduced as an automated closed system for GMP conform isolation and expansion of stem cells.

Simply fill out the form to watch the webinar.